Skip to main content
Tulane Home Tulane Home

Neurology ~ Research

Stroke Team Trials

Faculty Publications

Conference Presentations

 

 


 
Faculty Research Publications
  1. Alekseeva N, Mcgee J, Kelley RE, Maghzi AH, Gonzalez-Toledo E, Minager A., Toxic-metabolic, nutritional, and medicinal-induced disorders of cerebellum. Neurol Clin. 2014 Nov;32(4):901-11. doi:10.1016/j.ncl.2014.07.001. Epub 2014 Sep 11.Review. PMID: 25439288.
  2. Albright KC, Martin-Schild S, Bockholt HJ, Howard G, Alexandrov A, Alexandrov A, Sline MR, Grotta JC, and Savitz SI. No Consensus on Definition Criteria for Stroke Registry Common Data Elements.  Accepted in Cerebrovascular Diseases, September 2011.
  3. Albright KC, Alexandrov A, Howard G, and Martin-Schild S. Is There a Role for Echocardiography in Intracerebral Hemorrhage (ICH)? International Journal of Stroke 2010;5(5):383-4.
  4. Arthur JR, Lee J-P, Snyder EY, Seyfried TN. 2012 Therapeutic Effects of Stem Cells and Substrate Reduction in Juvenile Sandoff Mice. Neurochem Res. Jun;37(6):1335-43.
  5. Boehme AK Kumar AD, Dorsey AM, Siegler JE, Aswani MS, Lyerly MJ, Monlezun DJ, Albright KC, Beasley TM, Martin-Schild S.  Infections present on admission compared , Stroke Cerebrovascular Diseases, June 2013.
  6. Chang TR, Albright KC, Boehme AK, Dorsey A, Sartor EA, Kruse-Jarres R, Leissinger C, Martin-Schild S.  Factor VIII in the Setting of Acute Ischemic Stroke Among Patients with Suspected Hypercoagulable State.  Accepted in Clinical & Applied Thrombosis and Hemostasis, March 2013.
  7. Esse K, Fossati-Bellani M, Traylor A, and Martin-Schild S. Epidemic of Illicit Drug Use, Mechanisms of Action/Addiction and Stroke as a Health Hazard.  Brain and Behavior 2011; 1(1):44-54.
  8. Gonzalez R, Lee J-P, and Snyder EY, 2009. Neural stem cells for central nervous system repair. In Lanza R (ed). Essentials of Stem Cell Biology, Second Edition. Elsevier, pp 485-496.
  9. Gonzalez R, Hamblin M, Lee J-P. Neural Stem Cell Transplantation and CNS Diesases. 2014. CNS &Neurological Disorders – Drug Targets. (invited review, book chapter).
  10. Huang L, Snyder EY, Hamblin MH, Wong S, Lee J-P. 2014. Human Neural Stem Cells Rapidly Ameliorate Symptomatic Inflammation in Early-Stage Ischemic-Reperfusion Cerebral Injury. Submitted.
  11. Ijichi K, Brown GD, Moore CS, Lee J-P, Paige N, Winokur PN, Pagarigan R, Snyder EY, Ernesto R. Bongarzone ER, Croker SJ. 2013. MMP-3 Mediates Psychosine-induced Globoid Cell Formation: Implications for Leukodystrophy Pathology. Gila. May;61(5):765-77.
  12. Javalkar V, Kelley RE, Gonzalez-Toledo E, McGee J, Minager A. Acute ataxias:differential diagnosis and treatment approach. Neurol. Clin. 2014 Nov;32(4):881-91. doi:10.1016/j.ncl.2014.07.004. Epub 2014 Oct. 24. Review. PMID: 25439286.
  13. Jeyakumar M, Lee J-P, Sibson NR, Lowe JP, Stuckey DJ, Tester K, Fu G, Newlin R, Smith DA, Snyder EY and Platt FM. 2009. Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease. Stem Cells., Sep;27(9):2362-70.
  14. Jones EM, Albright KC, Fossati-Bellani M, Siegler JE, and Martin-Schild S.  Emergency Department Shift Change is Associated with Pneumonia in Patients with Acute Ischemic Stroke.  Stroke 2011;42(11):3226-30.
  15. Kelley R, DasMahapatra P, Wang Jian, Chen W, Srinivasan SR, Fernandez C, Xu JH, Martin-Schild S, and Berenson GS.  Prevalence of Atherosclerotic Plaque Formation in Young and Middle Age Asymptomatic Individuals:  The Bogalusa Heart Study.  Southern Medical Journal 2011;104(12):803-8.
  16. Kelley RE and Martin-Schild S.  Ischemic Stroke:  Emergencies and Management. Neurologic Clinics 2012;30(1):187-210.
  17. Kelley RE. Combined antithrombotic therapy of potential value in acute atrial related stroke. Eur J Neurol.2015 Jul:22(7):1027-8. doi:10.1111/ene.12588. Epub 2014 Nov 7. PMID:25382709.
  18. Chernyshev OY, Martin-Schild S, Albright KC, Barreto AD, Misra V, Acosta I, Grotta JC, and Savitz SI. Safety of t-PA in Stroke Mimics and Neuroimaging-Negative Suspected Cerebral Ischemia.Neurology 2010;74:1340-1345.
  19. Kelley, RE. Combined antithrombotic therapy of potential value in acute atrial fibrillation related stroke. Eur J Neurol. 2015 Jul;22(7):1027-8. doi:10.1111/ene.12588. Epub 2014 Nov 7. PMID:25382709.
  20. Kelley, RE. Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient. J Neurovirol. 2015 Feb;21(1):98-100. doi:10.1007/s13365-014-0301-3. Epub 2014 Nov 4. PMID:25366662.
  21. Kelley, RE, Andersson HC. Disorders of purines and pyrimidines. Handb Clin Neurol. 2014;120:827-38. doi:10.1016/B978-0-7020-4087-0.00055-3. PMID:24365355.
  22. Kumar AD, Siegler JE, Gillette M, Boehme AK, Albright KC, Martin-Schild S. Leukocytosis in Patients with Neurological Deterioration Following Acute Ischemic Stroke is Associated with Poor Outcomes.  Accepted in Journal of Stroke and Cerebrovascular Diseases, August 2012.
  23. Lee J-P, McKercher S, Muller FJ, and Snyder EY. 2008. Neural Stem Cell Transplantation in mouse brain. Current protocol in neuroscience (invited review from John Wiley & Sons, Inc.). Jan; Chapter 3: Unit 3.10.
  24. Lee J-P, Tsai DJ, Harvey HR, Park KI, and Snyder EY. 2009. The dynamics of Long-Term Transgene Expression in Engrafted Neural Stem Cells, J. Com. Neurol., July 1, 515 (1):83-92.
  25. Lee J-P, McKercher S, Muller FJ, Loring J and Snyder EY. 2009. Neurol Stem Cells and CNS diseases. In: Squire LR (ed). Encyclopedia of neuroscience, Vol 6, pp-229-237. Oxford: Academic Press. (Book Chapter).
  26. Leung LY, Albright KC, Boehme AK, Tarsia J, Shah KR, Siegler JE, Jones EM, Pletsch GR, Beasley TM, Martin-Schild S.  Short-term Bleeding Events Observed with Clopidogrel Loading in Acute Ischemic Stroke Patients.  Accepted in Journal of Stroke and Cerebrovascular Diseases, February 2013.
  27. Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, Simon RP, McGuire D, Kent TA.  Outcomes after tPA in African American Women with Explicit Consideration of Baseline Factors.  Accepted in Stroke, March 2013.
  28. Martin-Schild SAlbright KC, Hallevi H, Barreto AD, Philip M, Misra V, Grotta JC, and Savitz SI. Intracerebral hemorrhage in cocaine users.  Stroke 2010;41:680-684.
  29. Martin-Schild SAlbright KC, Tanksley J, Pandav V, Jones E, Grotta JC, Savitz SI. Zero on the NIHSS Does NOT Equal the Absence of Stroke. Annals of Emergency Medicine 2011;57(1):42-5, Epub Sep 15 2010.
  30. Martin-Schild S tPA for Stroke – Are We Ready to Remove the Barriers?  European Journal of Neurology 2011;19(3):359.
  31. Sarraj A, Medrek S, Albright K, Martin-Schild S, Vahidy F, Grotta JC, Savitz SI. Posterior Circulation Stroke is Associated with Prolonged Door-to-Needle Time.  Accepted in International Journal of Stroke, June 2012.
  32. Shaban A, Albright KC, Boehme AK, Martin-Schild S.Circle of Willis Variants; Part 1. Fetal PCAStroke Research and Treatment, vol. 2013, Article ID 105937, 6 pages, 2013. Doi:10.1155/2013/105937.
  33. Siegler JE and Martin-Schild S.Early Neurological Deterioration (END) after Stroke: The END Depends on the Definition. International Journal of Stroke 2011;6(3):211-2.
  34. Siegler JE, Boehme AK, Kumar AD, Gillette MA, Albright KC, Beasley TM, Martin-Schild SIdentification of modifiable and non-modifiable risk factors for neurological deterioration following acute ischemic stroke.  Accepted in Journal of Stroke and Cerebrovascular Diseases, November 2012.
  35. Siegler JE, Boehme AK, Dorsey AM, Monlezun D, George A, Shaban A, Bockholt HJ, Albright KC, Martin-Schild S.  A Comprehensive Stroke Center Registry: Advantages, Limitations, and Lessons Learned.  Medical Student Research Journal (2013) 1 (2):21-9. 
  36. Siegler JE, Kumar AD, Gillette MA, Boehme AK, Albright KC, Martin-Schild SWhat change in the NIH Stroke Scale should define neurological deterioration in acute ischemic stroke?  Journal of Stroke and Cerebrovascular Diseases, 2012.
  37. Siegler JE, Boehme AK, Albright KC, and Martin-Schild SEthnic disparities trump other risk factors in determining delay to Emergency Department arrival in acute ischemic stroke.  Accepted in Ethnicity & Disease, July 2012.
  38. Siegler JE, Boehme AK, Albright KC, Bdeir S, Kar AK, Myers L, Beasley TM, Martin-Schild SAcute decrease in serum magnesium level after ischemic stroke may predict decrease in neurologic function.  Accepted in Journal of Stroke and Cerebrovascular Diseases, May 2013.
  39. Siegler JE, Boehme AK, Albright KC, George AJ, Monlezun DJ, Beasley TM, Martin-Schild S. A proposal for the classification of etiologies of neurologic deterioration following acute ischemic stroke. Accepted in Journal of Stroke Cerebrovascular Diseases, June 2013.
  40. Siegler JE and Martin-Schild S.  Letter regarding article, "Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis."  Accepted in Stroke, May 2013.
  41. Siegler JE, Boehme AK, Fowler BD, George AJ, Monlezun DJ, Albright KC, Beasley TM, Martin-Schild S. Inpatient rehabilitation centers and concern for increasing volume of ischemic stroke patients requiring rehabilitation. Accepted in Southern Medical Journal, June 2013.
  42. Zhang R, Lee J-P, Snyder E and Huang Z. A de-novo designed CXCR4 synthetic agonist direct targeted human neural stem cell migration. 2014. Manuscript in preparation for submission to Nature Biotechnology.

 
Conference Presentations & Participation

Presenter: Dr. Jeffrey Nicholl
Psychiatric Complications of Epilepsy
Brain and Behavior Conference
Tulane University
December 12, 2014

Presenter: Dr. Jeffrey Nicholl and K. Mattes
The Law and Neuroscience Conference
Supreme Court of the Dominican Republic
February 16, 2015

Presenter: Dr. Jeffrey Nicholl
Diagnosis and Treatment of Status Epilepticus in the ICU
Tulane University
February 26, 2015

Presenter: Dr. Jeffrey Nicholl
Epilepsy and the Law
Tulane University
June 5, 2015

Presenter: Dr. Jeffrey Nicholl
"Forensic Neurology"
Tulane University Grand Rounds
June 5, 2015